Use of recombinant activated factor VII in Primary Postpartum Hemorrhage – its necessity in supply to the peripheries | Zendy

Madhusudan Dey | Zendy; Reema Kumar | Zendy; Nagaraj Narayan | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Use of recombinant activated factor VII in Primary Postpartum Hemorrhage – its necessity in supply to the peripheries

Author(s) -

Madhusudan Dey,

Reema Kumar,

Nagaraj Narayan

Publication year - 2013

Publication title -

international journal of biomedical and advance research

Language(s) - English

Resource type - Journals

eISSN - 2455-0558

pISSN - 2229-3809

DOI - 10.7439/ijbar.v4i1.933

Subject(s) - recombinant dna , primary (astronomy) , medicine , factor (programming language) , obstetrics , chemistry , computer science , biochemistry , physics , astronomy , gene , programming language

Postpartum hemorrhage (PPH) is a life-threatening emergency in obstetrics. In some critical cases, hemostasis is hard to achieve even after a hysterectomy has been performed. Early, effective and preferably non invasive treatments that can reduce maternal mortality and morbidity are therefore essential. Recombinant activated factor seven (rFVIIa) has been reported as a promising adjuvant therapy for obstetric hemorrhage, although it remains unlicensed for this indication. We are presenting four cases of primary PPH successfully managed using rFVIIa.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research